rfhg_27145.1

Basic information about the TSS

---

TSS ID: rfhg_27145.1 Species: human Chr: chr2		Start: 61537971 End: 61537979 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3130357,EH38E2002043)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000678172.1:191 ENST00000678360.1:191 ENST00000678081.1:191 ENST00000676889.1:191 ENST00000677290.1:191 ENST00000677850.1:191 ENST00000676789.1:191 ENST00000678741.1:191 GeneID: 7514 HGNC/MGI_ID: HGNC:12825 UniProt_ID: Nearer transcript ids and distances: ENST00000676783.1:197 ENST00000679035.1:215 ENST00000677150.1:-218 ENST00000678182.1:-248 AK312426:250 ENST00000677928.1:-252 ENST00000428210.5:-252 AL833550:-252 ENST00000677422.1:255 BC032847:-255 ENST00000406957.5:-269 ENST00000481214.1:277 CR749840:-279 BX647758:-287 ENST00000678790.1:-319 ENST00000677803.1:-377 ENST00000677239.1:-377 ENST00000401558.7:-377 NM_003400.4:-377 Y08614:378 view more...

Gene_name: exportin 1 Gene_symbol: XPO1 Gene_synonyms: CRM-1 CRM1 emb Gene_source: HGNC:12825

TATA-Box annotation

---

Distance to TSS:	381
Nearest PromoterID:	NM_003400
Entrez ID:	7514
Nearest Unigene:	Hs.370770
Nearest Refseq:	NM_003400
Nearest Ensembl:	ENSG00000082898
Gene Name:	exportin 1
Gene Alias:	CRM-1|CRM1|emb|exp1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@XPO1 p2@XPO1 p3@XPO1 p4@XPO1 p7@XPO1 p9@XPO1
Sample		p1@XPO1	p2@XPO1	p3@XPO1	p4@XPO1	p7@XPO1	p9@XPO1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	40.71	9.35	3.70	1.95	0.78	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	44.31	10.72	3.44	0.61	0.81	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.75	12.92	4.44	1.35	0.39	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	35.55	10.81	3.53	1.87	1.04	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	34.19	13.27	3.37	0.90	0.67	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	34.69	11.05	4.07	0.97	1.16	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	65.58	10.02	3.70	2.83	1.96	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	64.19	9.93	4.36	0.48	0.48	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	56.42	8.55	3.21	1.50	1.28	3.63
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	97.96	4.06	1.74	1.74	1.16	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	78.42	2.43	2.02	4.04	0.81	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	80.50	1.63	2.03	4.07	0.41	4.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.89	12.09	0.16	0.64	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	17.14	9.17	0.30	0.45	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.93	10.10	0.44	0.88	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.87	7.04	0.25	0.25	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	18.13	6.12	0.00	0.22	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.34	6.75	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	8.00	0.00	0.53	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.11	11.28	0.30	0.15	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.25	8.82	0.80	0.27	0.53	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.54	8.80	0.35	0.35	1.21	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.74	9.05	0.52	0.26	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.29	7.04	0.49	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.61	8.77	0.26	0.26	1.29	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	9.50	0.32	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	5.49	0.55	2.20	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.22	11.08	0.71	0.24	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.57	8.56	0.48	0.97	0.65	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	9.41	0.36	0.18	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	6.70	0.00	0.21	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.22	7.23	0.00	0.20	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.97	6.75	0.63	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.54	8.91	0.00	0.16	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.28	8.98	0.37	0.00	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.22	7.66	0.19	0.77	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.85	7.15	0.41	0.20	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.47	6.45	0.60	0.00	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.07	8.64	0.27	0.27	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	7.68	0.00	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	5.88	0.47	0.24	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.81	5.86	0.29	0.29	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.12	5.48	0.21	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.57	5.59	0.17	0.35	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.24	5.82	0.20	0.80	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.31	4.65	0.00	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.88	7.20	0.00	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	7.45	0.00	0.30	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.49	5.27	0.96	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.31	5.66	0.40	0.40	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.71	6.56	0.82	0.82	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.34	6.89	0.22	0.67	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	27.98	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.77	6.74	1.42	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.27	3.98	0.66	0.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	5.87	0.00	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.86	6.89	0.46	0.92	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.91	7.78	0.32	0.65	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.53	6.74	0.00	0.64	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	12.89	11.94	0.94	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	4.23	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	2.80	0.00	0.00	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	10.35	0.80	2.39	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.97	7.47	0.00	0.68	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.27	6.17	0.97	0.65	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.04	4.97	0.35	0.35	0.71	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	15.79	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	8.78	0.49	0.98	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	6.94	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	8.91	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.55	15.90	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.23	10.52	0.31	0.31	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.31	7.95	0.61	0.31	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	12.83	5.39	0.95	0.16	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	12.67	9.14	1.28	0.16	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	16.67	6.87	0.51	0.13	0.13	0.76
Adipocyte - omental, donor2	11474-119C7	10.46	2.99	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	10.05	2.68	1.34	1.00	0.67	1.00
Adipocyte - perirenal, donor1	11476-119C9	8.93	3.83	0.64	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	1.10	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.97	8.58	0.45	0.00	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	2.95	0.35	0.00	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	23.66	10.76	0.98	1.17	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	18.79	13.13	0.51	0.51	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	34.57	13.38	2.23	0.84	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	16.46	10.58	1.18	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	8.53	16.57	1.69	0.97	0.48	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	8.07	14.85	0.65	0.65	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	6.93	10.13	0.53	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	10.02	1.11	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.15	17.47	1.25	0.83	1.66	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	5.53	14.07	1.00	0.75	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	11.78	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	12.18	1.22	0.30	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	7.73	4.64	0.44	1.10	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	1.08	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.57	1.62	0.54	0.36	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.83	3.70	0.21	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	31.81	9.73	0.46	1.37	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	19.10	7.35	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	6.74	1.35	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.72	9.99	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	6.42	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.66	6.28	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	5.06	2.53	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	6.60	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.72	4.87	0.65	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.68	5.83	0.00	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.88	9.50	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.43	4.52	0.75	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.16	5.08	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	1.25	1.25	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.53	6.59	0.33	0.33	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	5.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.90	6.48	0.90	0.15	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	4.29	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.71	4.72	0.57	0.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	6.15	0.80	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	7.80	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.61	6.47	0.17	0.66	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	3.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.98	5.49	0.51	0.34	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.65	7.77	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.18	6.45	0.38	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	4.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	6.27	2.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.62	7.27	0.64	0.00	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	6.19	0.52	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.67	8.45	0.94	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.25	5.47	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	4.28	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	6.43	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.45	8.13	0.30	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	8.32	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	7.12	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.01	8.15	1.02	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	4.45	0.00	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	12.51	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.28	8.89	1.48	0.42	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.57	3.77	0.29	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	8.50	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.21	7.29	0.00	0.17	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	6.95	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	8.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.86	6.86	1.29	0.64	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	6.62	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	2.92	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.20	6.44	0.69	0.00	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	5.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.17	5.59	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.97	6.19	0.21	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.73	6.43	0.61	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.65	7.65	0.96	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.75	6.21	0.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	4.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	8.31	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.92	5.03	0.00	0.79	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.81	3.27	0.73	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	14.74	7.86	0.49	0.37	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	12.32	3.94	1.03	0.51	0.17	0.34
Astrocyte - cerebellum, donor3	11661-122F5	5.87	2.94	0.00	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	48.80	23.36	1.74	1.39	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	71.18	26.69	2.91	0.65	0.65	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	68.17	25.06	2.39	1.04	0.75	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	70.65	39.68	2.98	2.06	0.80	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	84.31	41.97	3.63	2.13	1.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	76.93	50.07	3.30	2.73	0.68	0.11
Basophils, donor1	12241-129G9	4.18	5.49	0.00	0.52	0.00	0.00
Basophils, donor2	12242-129H1	11.18	9.74	0.36	1.80	0.00	0.36
Basophils, donor3	12243-129H2	9.41	5.88	0.73	0.59	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	6.90	0.65	0.00	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.49	1.83	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.67	6.28	1.26	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.02	3.33	0.21	0.21	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	10.36	1.61	0.46	0.00	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	23.21	5.58	0.54	0.00	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	79.25	22.67	5.67	1.24	1.24	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	63.35	28.65	5.59	0.70	2.10	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	38.37	23.98	1.28	0.96	1.28	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.89	10.71	0.00	1.13	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	7.61	7.98	0.00	0.37	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	10.76	7.90	0.00	0.00	0.88	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.32	23.21	1.13	0.57	1.42	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	30.33	20.47	1.14	0.76	1.52	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	23.01	0.99	0.33	1.97	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	9.97	6.94	0.87	0.72	0.87	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	5.73	3.32	0.00	1.51	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	8.29	3.55	0.47	0.47	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.87	3.18	0.50	0.50	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	1.10	0.00	0.55	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.45	1.98	0.50	0.99	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.35	1.37	0.00	0.78	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.56	2.49	0.00	0.53	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2.39	0.65	0.00	0.65	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.98	1.17	0.23	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.17	4.22	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.84	2.53	0.30	0.15	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.39	1.80	0.00	0.20	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.25	2.50	0.21	0.62	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.35	1.83	0.00	0.92	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.30	1.58	0.00	0.68	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.18	1.31	0.00	0.87	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	7.80	1.61	0.81	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.31	2.62	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.63	3.37	0.42	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.06	1.29	0.18	0.73	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.93	1.76	0.35	1.41	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.95	1.32	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.96	1.39	0.17	0.17	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.23	3.72	0.00	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.80	1.08	0.00	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	3.28	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.94	0.93	0.00	0.23	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.02	0.46	0.00	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	11.55	8.28	0.44	1.74	0.22	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	13.63	16.63	0.00	1.62	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	8.88	9.53	0.43	0.43	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	15.57	13.39	0.16	1.09	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	12.23	13.10	0.70	0.52	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	20.07	18.95	0.00	1.34	0.67	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	9.95	9.70	1.28	0.51	0.26	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	12.52	13.61	0.88	1.10	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	7.16	12.63	0.42	0.63	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	10.16	0.00	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	19.66	20.34	0.00	4.75	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	45.57	19.68	2.07	3.11	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	30.38	36.25	1.60	0.53	0.00	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	29.48	38.06	0.54	4.82	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	20.36	19.65	0.00	2.81	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	24.31	1.57	0.78	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	23.73	0.00	1.32	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	17.26	19.73	0.82	2.47	3.29	3.29
CD19+ B Cells, donor2	11624-122B4	15.96	11.61	0.00	2.18	0.73	2.18
CD19+ B Cells, donor3	11705-123B4	21.71	11.11	0.00	3.53	0.00	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	100.21	18.59	3.23	1.21	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	81.50	15.18	1.60	0.40	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	2.01	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	8.43	1.69	0.00	0.56	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.47	20.67	1.13	1.50	1.88	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	46.45	24.58	0.68	1.58	0.23	0.45
CD4+ T Cells, donor1	11225-116C1	22.49	17.85	0.00	1.07	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	25.11	14.70	0.61	1.22	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	25.62	12.20	0.61	0.91	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	18.12	15.57	0.51	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.95	15.50	0.90	1.35	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	18.11	20.12	1.15	0.57	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	34.13	14.22	0.95	2.37	0.47	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.90	10.53	0.00	1.40	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	9.89	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	22.98	14.16	0.14	0.29	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	30.16	16.95	0.85	0.34	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.15	16.93	0.64	0.48	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.83	10.31	0.45	1.79	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	22.71	11.18	0.70	0.35	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.92	19.36	0.88	0.88	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	30.78	16.02	0.00	1.26	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	46.96	13.09	1.25	0.62	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	48.45	18.71	0.67	2.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	39.16	13.60	0.54	1.63	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	39.66	14.47	0.54	2.68	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	14.35	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.93	27.44	1.30	1.30	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	26.64	13.00	0.00	1.52	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	30.26	20.81	1.26	0.42	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	19.72	14.16	0.00	1.52	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.06	13.00	0.43	0.87	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	48.81	16.56	1.31	1.74	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	47.01	26.23	0.00	0.99	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	40.62	12.92	0.00	1.85	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	34.90	0.00	1.40	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	32.68	33.51	0.28	1.38	1.11	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	27.48	29.94	0.98	1.96	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	55.44	24.64	1.54	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	62.31	32.59	0.72	3.22	2.51	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	34.62	1.38	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	27.50	18.33	0.65	0.65	0.00	1.96
CD8+ T Cells, donor2	11307-117C2	27.78	15.02	0.00	0.38	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	33.33	23.48	1.26	0.50	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.12	2.98	0.69	0.46	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.38	2.40	0.72	0.00	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.51	1.37	1.09	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.71	1.20	0.60	0.30	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.00	1.68	1.20	0.00	0.72	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.78	2.73	1.59	0.23	1.14	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.20	2.82	1.09	0.43	0.65	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	20.27	2.90	1.58	0.00	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	23.45	4.46	1.41	0.23	0.94	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.96	3.02	2.72	0.60	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.31	2.61	1.16	0.87	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	33.04	2.40	0.53	0.27	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.89	1.75	0.44	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	24.14	1.82	0.91	0.91	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	0.75	2.98	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.97	2.88	0.36	0.36	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.80	2.30	0.58	0.00	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.73	2.59	0.24	0.24	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	35.81	3.17	0.63	0.95	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.14	2.46	0.92	0.00	1.54	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.61	3.21	0.64	0.32	0.64	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.16	0.76	0.76	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.04	1.97	0.79	1.18	0.79	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	2.27	0.00	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.10	0.80	3.21	0.00	4.01	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	31.47	0.00	1.40	0.00	2.10	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	24.04	5.01	0.00	0.00	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	54.83	10.97	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	20.75	5.93	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	29.78	3.89	0.84	0.63	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	27.39	6.93	1.39	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	13.86	4.98	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	25.15	4.78	0.34	1.02	0.23	0.11
Chondrocyte - re diff, donor2	11339-117F7	15.22	5.37	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.41	5.26	0.00	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.90	17.90	1.26	1.38	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	39.97	8.12	0.43	0.86	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	44.43	9.82	1.33	1.06	0.53	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	29.89	17.61	1.83	0.64	0.46	0.64
Corneal Epithelial Cells, donor1	11526-119I5	5.49	1.32	0.00	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	10.23	1.28	0.51	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	17.67	22.29	1.49	0.17	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	16.09	23.02	1.89	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	6.90	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.49	22.35	1.30	0.22	0.32	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	16.40	17.08	0.00	0.00	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	26.11	15.67	1.96	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	20.33	14.52	0.00	1.45	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	15.68	9.84	0.83	0.33	0.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	2.93	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	14.99	5.37	0.57	0.85	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	14.15	6.29	0.79	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.07	2.62	0.00	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	26.82	8.00	0.94	0.47	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	17.18	6.49	0.70	0.70	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.08	19.51	1.55	0.66	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.95	14.60	0.91	0.30	0.61	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	16.91	19.73	0.56	1.41	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	8.62	4.16	0.30	0.59	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	13.54	9.37	0.52	1.04	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	7.37	4.82	0.57	0.00	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	21.21	11.60	0.80	0.40	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	2.62	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	39.14	37.65	3.60	2.48	0.50	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	31.72	24.99	1.30	0.43	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	33.46	28.94	2.32	0.85	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	25.03	6.83	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	6.29	0.70	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.63	13.66	0.94	0.31	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	8.25	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.66	0.73	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.04	4.52	1.23	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.21	2.30	0.22	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.28	4.55	0.33	0.11	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	37.84	6.55	0.73	0.36	0.61	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	82.57	10.51	3.00	0.14	0.41	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.09	5.17	0.63	0.11	0.11	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	76.68	4.74	2.37	0.53	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.52	7.97	1.00	0.33	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	20.87	3.63	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	16.67	1.52	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.51	3.00	0.79	0.32	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	30.31	11.21	0.61	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	28.30	10.15	0.89	0.13	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	29.86	13.04	0.76	0.91	1.06	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.18	3.08	0.54	0.54	0.00	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.00	5.61	0.00	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	10.25	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	16.38	3.00	0.46	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	29.68	11.87	0.68	0.85	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	15.73	11.74	0.47	0.23	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	12.74	6.13	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	18.98	13.06	0.85	0.60	0.36	0.60
Fibroblast - Dermal, donor4	11450-119A1	35.50	21.70	1.92	1.36	1.13	0.68
Fibroblast - Dermal, donor5	11454-119A5	35.07	21.81	1.92	1.40	0.52	0.70
Fibroblast - Dermal, donor6	11458-119A9	44.83	25.50	1.95	1.95	0.00	0.49
Fibroblast - Gingival, donor1	11237-116D4	23.53	11.04	1.04	1.04	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	35.89	6.29	0.52	0.52	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	34.79	26.49	1.19	1.32	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	32.49	12.96	0.97	0.77	0.87	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	12.47	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.96	4.76	0.53	0.70	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	50.98	13.56	2.03	0.78	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	37.73	12.44	1.08	1.49	0.68	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	41.64	10.23	2.12	1.06	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.29	12.58	1.17	0.58	0.15	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	33.54	13.23	0.95	0.55	0.68	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.79	12.51	2.19	0.99	0.33	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.79	10.71	1.03	0.59	0.44	0.29
Fibroblast - Lung, donor1	11270-116H1	9.52	2.72	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	23.87	1.49	2.98	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	19.20	20.05	1.27	0.21	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.00	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	11.77	5.28	1.22	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.60	30.84	2.33	2.13	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	54.00	39.59	3.64	2.43	0.30	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.94	14.08	1.22	0.61	0.92	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	35.87	6.87	0.00	1.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	32.13	3.78	0.54	0.54	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.02	8.00	0.70	0.46	0.93	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	35.04	11.50	1.33	0.77	0.00	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.55	4.88	0.20	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.01	6.01	0.67	0.00	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.93	9.88	0.40	1.58	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	90.89	11.31	2.58	1.59	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	20.43	4.62	0.53	0.71	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.82	6.70	0.20	0.00	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	65.29	5.72	1.20	1.20	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.99	7.56	0.86	0.97	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	60.23	5.06	2.53	0.25	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	21.49	4.43	0.49	0.16	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	111.68	14.64	2.61	1.00	0.60	0.60
Fibroblast - skin normal, donor2	11561-120D4	31.14	4.42	0.80	0.60	0.40	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	90.37	9.97	2.12	0.30	0.60	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.86	7.21	1.08	0.33	0.50	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.36	12.14	0.17	1.20	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	51.56	7.55	1.97	0.33	0.33	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	29.29	5.43	1.07	0.43	0.21	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	32.89	8.27	0.67	0.51	0.51	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.47	3.45	0.78	0.31	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	66.48	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	13.07	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.56	11.44	1.73	0.87	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.38	11.97	0.78	0.26	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	19.67	8.94	0.51	0.51	1.02	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	61.24	49.76	10.72	1.53	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	67.00	42.11	7.66	2.55	0.00	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	138.35	71.32	19.11	5.99	0.57	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	149.46	53.22	6.07	1.93	2.48	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	191.11	16.90	3.88	1.14	0.46	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	121.06	54.49	9.91	2.58	1.19	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	136.40	47.58	6.08	1.85	1.32	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	219.17	6.52	5.54	0.33	1.30	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	147.26	57.93	16.80	4.86	1.33	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	75.18	47.63	8.48	2.40	1.41	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	60.71	51.72	8.74	1.72	1.97	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	79.78	42.44	4.84	1.34	1.07	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.95	44.48	4.83	1.61	1.36	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.70	55.79	6.23	3.18	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.96	45.34	8.13	2.64	1.02	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.03	44.72	3.65	1.83	0.46	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.03	49.20	3.24	2.37	0.50	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	31.48	64.48	4.37	1.97	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.21	33.98	2.95	2.07	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.14	37.99	5.09	0.48	0.64	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.32	37.98	4.02	2.01	0.45	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.86	37.10	1.01	1.01	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	41.22	41.90	4.07	1.70	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	59.23	42.30	5.32	2.04	1.15	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.35	33.82	2.39	2.19	0.94	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.57	30.23	1.02	2.22	1.02	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.32	37.40	4.09	1.55	0.89	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.67	40.43	4.24	1.83	0.92	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.55	26.75	2.25	2.25	0.82	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.01	33.83	2.06	1.24	1.65	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.13	40.01	1.73	1.50	0.69	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	47.86	35.19	1.50	2.17	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.62	31.96	0.22	1.54	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.81	35.42	1.60	0.74	0.37	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	41.82	33.39	2.27	1.78	0.32	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	28.54	34.32	0.64	1.60	0.64	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.04	32.03	1.52	1.23	0.28	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.31	29.90	1.27	0.47	1.42	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.37	30.10	1.22	1.52	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.46	34.81	1.99	1.46	0.63	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	26.79	23.27	1.54	0.88	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	37.03	1.96	2.24	1.12	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.54	25.55	1.85	0.56	0.93	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.01	24.87	2.14	1.34	0.53	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	27.08	30.14	1.07	0.92	0.46	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.02	26.94	1.81	0.65	0.65	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.69	20.60	2.44	0.00	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	24.52	26.73	1.66	0.55	1.11	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.00	27.85	2.41	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	30.74	0.99	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.69	24.14	1.32	1.06	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	18.56	27.04	0.61	1.01	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	18.55	24.40	1.78	0.51	0.76	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	87.39	52.35	11.55	5.77	1.00	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	90.44	66.56	10.48	2.93	1.08	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	119.27	73.04	13.91	5.73	1.23	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	46.94	26.60	5.63	1.88	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	51.99	22.89	3.11	1.70	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	105.62	35.97	8.76	1.84	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	131.16	54.45	14.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	87.42	37.52	9.67	0.77	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	91.45	62.57	8.02	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	31.30	5.22	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	75.19	27.01	6.51	2.28	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	92.66	32.12	5.35	1.65	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	33.32	10.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	76.62	27.13	4.19	1.96	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	66.68	23.86	5.88	1.96	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	64.59	30.20	6.71	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	72.84	26.40	5.09	1.59	0.95	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	65.89	28.19	3.74	3.74	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	35.50	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	72.16	27.49	1.72	2.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	42.92	21.01	1.78	1.18	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	62.68	22.02	3.39	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	64.62	19.47	7.04	0.83	1.66	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	66.51	24.39	5.52	1.61	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	10.54	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	69.58	19.99	2.31	0.38	0.77	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	56.07	17.60	2.61	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	57.52	20.73	0.67	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	68.96	30.05	2.70	3.47	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	81.13	24.65	2.74	1.37	1.03	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	109.33	37.27	2.48	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	73.14	32.09	3.77	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	27.16	2.41	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	68.16	13.23	2.03	2.54	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	84.15	24.33	2.39	0.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	67.10	18.25	2.96	3.45	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	35.41	8.26	2.36	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.34	20.42	2.33	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	53.54	25.02	3.95	5.27	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	16.95	3.39	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	33.43	13.13	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.50	11.65	2.91	1.46	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	3.42	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	4.16	1.25	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	12.37	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.15	6.98	0.32	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.86	1.67	0.84	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.97	24.48	4.06	1.04	0.81	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.42	26.33	3.88	1.01	0.51	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.94	22.30	3.64	0.46	1.14	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	27.44	25.58	4.26	1.53	0.22	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	25.36	23.86	3.01	1.29	0.86	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.00	17.01	2.15	1.29	1.08	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.41	22.91	3.49	0.75	0.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.16	18.53	3.95	0.51	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.95	23.39	3.20	0.96	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	4.48	7.28	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.06	2.60	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	10.58	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	1.76	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	32.87	3.50	0.52	0.00	0.52	0.00
Hepatocyte, donor1	11523-119I2	12.11	10.90	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	4.31	25.86	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	18.41	14.11	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	95.29	26.76	1.31	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	59.78	11.71	1.92	1.05	0.87	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.83	9.19	0.82	0.55	0.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	52.61	1.38	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	47.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	64.07	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	76.34	6.50	1.62	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	48.35	8.34	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	5.29	3.97	0.00	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	46.56	5.54	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	43.46	10.08	4.41	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	72.69	6.19	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	53.62	5.17	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	82.11	8.05	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	143.38	11.95	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	61.12	8.96	1.63	0.00	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	48.70	3.36	3.36	0.00	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	46.61	8.84	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	25.85	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	35.40	5.19	2.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.02	2.72	1.81	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	44.12	8.61	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	53.36	2.54	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.99	5.74	0.00	0.00	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	56.50	1.82	1.82	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	46.41	4.28	2.86	0.00	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.31	4.32	2.47	0.31	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	1.76	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	48.68	6.26	0.70	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	75.25	4.43	0.00	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	12.97	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	56.68	4.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	67.49	6.75	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	64.01	4.27	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	44.33	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	56.99	14.25	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	59.83	6.44	2.76	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	18.63	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	45.47	4.23	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	22.85	4.90	0.57	0.49	0.16	0.08
Keratinocyte - epidermal, donor2	11349-117G8	8.20	1.76	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	32.37	9.18	0.85	0.28	0.28	0.28
Keratinocyte - oral, donor1	11251-116E9	48.47	11.58	0.68	1.48	0.45	0.23
Keratocytes, donor1	11527-119I6	15.13	2.41	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	15.23	2.34	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	36.95	4.54	0.00	0.40	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	4.40	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	12.94	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	41.87	15.34	0.81	1.15	0.58	0.69
Lens Epithelial Cells, donor3	11690-122I7	40.57	5.55	0.61	0.50	0.10	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.14	5.22	0.59	0.83	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.44	6.14	0.56	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.68	8.34	0.47	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	4.84	0.00	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.67	4.10	0.32	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.87	2.16	0.43	0.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.08	6.57	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	3.03	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.60	3.52	0.42	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	12.26	5.14	1.58	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.02	5.82	0.19	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.63	1.85	0.19	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	15.68	5.92	0.70	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.35	3.34	0.24	0.72	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.24	3.02	0.00	0.14	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.86	3.70	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	0.94	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.14	2.38	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.23	3.29	0.66	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	3.22	0.00	1.17	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.22	1.99	0.00	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.15	7.76	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.31	3.50	0.27	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.02	2.42	0.30	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	2.07	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.70	5.65	0.84	1.05	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.17	1.80	0.75	0.15	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	6.19	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.34	5.08	0.94	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.57	2.86	0.32	0.21	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.54	6.30	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.59	3.97	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.34	3.47	0.50	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	12.59	1.48	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.37	3.71	0.49	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.50	2.75	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.97	6.43	0.32	0.96	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.65	8.83	0.61	0.00	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.66	4.48	0.14	0.84	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.51	7.11	1.42	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	1.94	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.49	1.24	0.00	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.67	3.58	0.72	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.74	4.25	0.33	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.71	1.88	0.47	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.23	6.93	0.50	0.87	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.63	3.07	0.26	0.51	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	2.39	0.00	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	9.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	6.90	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	9.65	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	34.70	6.35	1.27	0.00	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.99	4.22	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15.88	6.54	1.87	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.70	4.64	0.00	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	33.30	4.76	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	25.11	4.30	1.81	0.90	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.41	7.27	2.04	1.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	27.91	6.75	1.80	1.35	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.32	7.18	1.35	0.81	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	30.81	4.62	2.05	1.03	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	26.82	5.65	1.76	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	16.66	2.67	1.33	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.05	6.62	0.51	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.35	5.60	1.33	1.60	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.90	6.80	2.46	0.94	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	7.98	0.00	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.06	8.15	1.63	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.19	8.12	1.25	0.62	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.34	6.17	1.12	1.40	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	28.85	3.09	2.06	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.68	7.84	1.16	1.45	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	29.89	5.08	1.20	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	33.75	4.98	0.55	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.52	8.48	1.77	0.71	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	29.87	5.53	2.58	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	6.91	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.61	6.52	1.54	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.08	5.10	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	3.28	3.28	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.05	6.78	0.00	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	27.29	5.03	2.15	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	6.72	2.24	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	28.61	5.95	1.11	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.72	4.31	0.86	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.11	5.14	3.43	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.32	5.66	0.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.93	1.81	1.21	0.60	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	7.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	30.25	8.59	0.69	0.00	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	5.37	1.61	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.26	5.39	3.37	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	31.11	5.93	1.48	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	31.40	3.49	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	10.58	0.00	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.21	6.00	0.80	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.16	4.36	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	6.90	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	31.08	4.93	0.99	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	32.93	10.35	0.94	1.88	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	32.68	6.03	1.01	0.50	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	35.15	4.96	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	8.61	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	35.18	6.23	1.78	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	31.28	7.82	1.17	2.35	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.01	5.28	0.66	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.62	7.26	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	39.82	8.75	0.44	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	39.70	6.15	0.56	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	31.80	4.42	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	33.17	5.40	1.16	0.39	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	31.90	5.57	1.52	1.01	0.51	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	29.32	7.21	0.96	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	33.79	8.75	0.40	1.59	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	6.08	0.00	1.82	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	3.46	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	29.26	3.04	1.52	1.52	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	34.08	4.65	1.55	2.07	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	17.53	4.23	0.60	0.00	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	39.30	7.61	1.27	1.58	0.00	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.79	3.73	1.60	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.22	3.45	0.57	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	38.57	6.69	0.51	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	27.59	7.78	0.00	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	2.84	1.70	1.13	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.53	6.24	2.08	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	29.76	4.70	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	4.59	1.25	1.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	28.34	4.18	0.93	0.93	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	4.01	1.34	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.23	4.28	0.00	2.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	27.07	7.68	1.62	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	28.45	2.75	0.92	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	6.22	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	31.34	5.13	1.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	31.44	6.90	3.83	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.06	4.38	0.55	1.64	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.08	4.01	0.89	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.52	7.02	1.82	0.52	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.86	5.30	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	4.16	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	21.20	23.02	1.14	1.82	0.46	0.46
Macrophage - monocyte derived, donor2	11313-117C8	16.70	13.58	0.92	0.00	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	25.43	19.14	0.92	0.66	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.15	4.25	1.06	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	25.99	4.75	0.32	0.32	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	22.10	7.92	1.53	0.14	0.69	0.00
Mammary Epithelial Cell, donor1	11273-116H4	55.30	4.78	1.79	0.60	0.60	0.40
Mammary Epithelial Cell, donor2	11350-117G9	51.83	8.40	1.74	0.00	0.00	0.87
Mammary Epithelial Cell, donor3	11422-118F9	13.72	3.99	1.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	8.14	2.03	0.00	0.00	0.68	0.68
Mast cell, donor1	11563-120D6	32.66	5.73	0.22	1.19	0.22	0.11
Mast cell, donor2	11565-120D8	63.89	11.59	0.30	0.89	0.89	1.19
Mast cell, donor3	11566-120D9	81.95	14.63	0.45	1.35	1.58	0.90
Mast cell, donor4	11567-120E1	78.01	15.96	0.35	1.24	1.24	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	45.36	9.43	0.22	1.11	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	28.02	12.84	0.58	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	36.83	10.67	0.80	0.57	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	28.12	19.75	0.00	1.84	0.67	0.17
Melanocyte - dark, donor1	11502-119F8	16.72	20.50	1.19	1.39	0.40	0.20
Melanocyte - dark, donor2	11582-120F7	24.57	5.19	1.73	0.69	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	32.38	34.26	1.74	1.16	0.87	0.94
Melanocyte - light, donor1	11274-116H5	13.63	9.87	0.47	0.00	0.71	0.47
Melanocyte - light, donor2	11351-117H1	4.09	10.92	0.00	0.00	0.00	1.36
Melanocyte - light, donor3	11423-118G1	7.81	11.27	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.77	47.69	2.71	1.25	0.10	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	11.83	33.62	3.50	1.88	0.27	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	8.04	32.68	2.41	1.34	0.80	1.34
Meningeal Cells, donor1	11493-119E8	12.53	12.28	0.50	0.99	0.37	0.00
Meningeal Cells, donor2	11573-120E7	14.52	5.28	0.44	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	44.50	26.41	1.87	2.28	0.82	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	42.20	19.11	2.28	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.96	6.24	0.70	0.20	0.40	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	2.63	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	2.62	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.12	12.20	0.72	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.64	8.68	0.21	0.21	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.17	7.04	3.52	0.50	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	17.36	6.15	1.10	1.10	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	15.34	2.92	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.21	2.25	0.61	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.25	9.42	0.42	0.55	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.46	3.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	32.10	7.24	1.18	0.53	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.23	0.00	0.00	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	2.56	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.52	23.75	1.77	0.71	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	26.58	5.32	0.63	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.01	10.16	0.73	1.45	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	9.81	5.04	0.53	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	8.01	3.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	15.18	3.97	0.58	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	29.71	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.10	23.64	0.99	0.25	0.99	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	22.08	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	6.91	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.30	13.64	0.93	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.30	15.97	0.41	0.41	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	13.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.51	22.27	1.00	1.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.71	18.62	0.00	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.10	17.07	0.61	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.13	16.63	1.58	0.79	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	15.93	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	13.68	0.76	0.00	0.38	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	13.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.94	14.01	1.06	0.64	0.85	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	18.42	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.66	16.99	0.89	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	11.74	1.68	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.27	12.29	0.75	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.89	13.78	0.24	0.95	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	8.29	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.68	7.14	1.15	0.23	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.05	11.15	0.63	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.11	12.84	0.41	0.41	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.79	11.59	0.43	0.64	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.56	10.67	0.89	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.07	8.10	0.22	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	6.08	0.51	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	9.94	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.71	9.24	1.90	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	6.47	0.88	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	11.99	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.40	5.77	0.48	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	6.40	2.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	10.97	2.74	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.00	3.50	0.50	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.38	5.69	0.00	0.44	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	5.52	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	8.97	1.92	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.45	4.96	0.99	0.25	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	6.26	0.00	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	11.05	0.00	0.00	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.84	4.79	0.34	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.75	5.69	0.88	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.18	6.04	2.84	0.36	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.66	5.61	1.12	0.00	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.13	6.23	0.83	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	5.83	2.33	0.00	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.27	6.03	0.90	0.00	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	19.62	4.59	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	7.22	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	9.24	2.77	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	23.90	5.69	3.41	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.58	4.70	1.11	0.28	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.47	5.44	0.78	0.78	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.31	3.86	0.86	0.86	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	25.41	8.26	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.69	5.07	1.60	0.00	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.45	9.88	1.20	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.69	6.22	0.42	0.57	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.47	5.10	0.32	0.32	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	7.08	2.87	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.79	4.93	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	26.42	6.53	1.14	0.57	1.14	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	29.74	5.90	1.97	0.25	0.49	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	10.43	1.96	0.00	1.30	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.76	5.00	1.47	0.00	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.35	6.63	1.15	0.58	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.49	10.30	0.41	0.41	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.12	7.74	1.19	0.30	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30	0.00	0.00	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	19.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.91	16.43	0.00	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	13.68	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.72	18.78	0.99	0.00	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	20.49	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.51	12.77	0.00	1.13	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.92	9.85	2.13	0.80	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.37	14.59	1.13	0.57	0.57	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	5.89	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.23	14.66	1.10	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	10.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.88	15.50	0.00	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	11.11	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	12.65	0.84	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	39.50	6.81	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	2.54	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.82	0.81	0.00	0.00	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	45.31	7.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	119.91	5.71	0.00	5.71	5.71	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	120.71	6.52	3.26	3.26	3.26	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	12.55	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	29.51	5.82	0.86	0.22	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	32.40	3.66	0.52	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	10.01	0.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	5.84	0.42	0.00	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	44.30	27.76	2.66	1.14	1.52	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	36.70	22.34	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	5.44	0.68	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	27.56	14.70	1.84	0.00	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	12.56	0.42	1.67	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.03	11.62	2.32	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	10.00	0.27	0.81	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.81	14.30	1.05	0.84	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	189.29	77.94	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	8.44	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	13.53	17.05	1.89	0.54	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.56	8.84	1.13	0.23	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.14	10.29	0.98	0.49	0.33	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.95	11.85	1.09	0.73	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.08	9.55	0.00	1.06	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	6.60	1.20	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.78	27.24	1.64	1.64	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.81	7.81	1.46	0.33	0.33	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.29	13.76	1.06	0.88	0.71	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	9.85	0.70	0.00	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	10.57	0.46	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.75	12.53	0.96	0.32	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.31	20.00	2.07	1.03	1.72	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	45.51	35.40	2.53	2.53	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.37	16.26	0.22	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	7.62	2.12	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.21	21.60	0.71	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.02	15.45	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.00	8.33	0.00	0.33	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	3.61	1.35	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.70	6.35	1.19	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	10.22	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.49	17.78	1.14	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.04	3.26	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	6.54	0.00	0.00	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	9.05	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	2.65	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	16.62	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	8.93	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.80	2.68	0.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.08	24.80	2.42	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.49	8.40	0.88	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	9.49	6.78	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	61.31	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	8.54	1.83	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.55	5.35	0.63	0.31	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.45	9.38	0.61	0.30	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	11.08	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	9.07	0.00	2.27	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	55.64	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.70	4.97	1.99	0.00	0.12	0.37
Myoblast, donor2	11322-117D8	33.37	12.66	1.53	0.38	0.38	0.00
Myoblast, donor3	11398-118D3	35.48	13.28	2.19	0.50	0.00	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	51.81	21.31	1.31	0.58	0.73	0.29
Natural Killer Cells, donor1	11230-116C6	25.83	20.91	0.92	1.23	0.31	1.23
Natural Killer Cells, donor2	11311-117C6	24.12	12.97	0.30	0.90	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	27.42	15.28	0.18	0.74	0.18	0.00
Neural stem cells, donor1	11275-116H6	54.08	33.03	0.36	2.18	0.00	1.81
Neural stem cells, donor2	11352-117H2	46.22	15.41	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	56.89	7.97	1.14	1.14	1.14	1.14
Neurons, donor2	11574-120E8	40.29	17.83	1.32	0.66	1.10	0.44
Neurons, donor3	11655-122E8	47.69	9.87	0.00	0.82	0.00	1.64
Neutrophils, donor1	11233-116C9	2.78	8.35	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	23.21	8.55	0.00	0.61	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	39.90	7.72	1.31	0.47	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	24.42	5.21	0.65	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.06	8.42	0.20	0.20	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	11.01	6.88	0.14	0.28	0.14	0.69
Olfactory epithelial cells, donor2	11934-125I8	21.57	4.78	0.87	0.58	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	14.64	4.77	0.68	0.23	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	18.90	12.95	0.58	0.97	0.10	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	38.52	17.45	1.81	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	11.70	6.17	0.21	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	4.57	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.07	3.72	0.62	1.24	0.62	0.62
Osteoblast, donor1	11277-116H8	10.55	1.17	0.39	0.20	0.00	0.39
Osteoblast, donor2	11354-117H4	43.54	7.02	2.11	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	31.28	5.51	0.36	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	40.85	14.99	1.35	0.59	0.25	0.17
Pericytes, donor1	11491-119E6	4.01	2.11	0.11	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	6.56	1.13	0.23	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	8.75	3.26	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	34.36	12.55	0.90	0.79	0.11	0.23
Perineurial Cells, donor2	11579-120F4	25.30	8.37	0.83	1.38	0.55	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	16.26	24.22	0.96	0.32	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.08	14.45	0.49	0.00	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.13	15.27	0.65	0.91	0.26	0.52
Placental Epithelial Cells, donor1	11278-116H9	10.04	1.43	0.72	0.24	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	2.22	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.62	1.96	0.20	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.96	2.53	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	17.63	3.75	0.38	0.19	0.00	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	37.72	6.40	1.44	0.39	0.39	0.52
Preadipocyte - breast, donor2	11328-117E5	18.01	5.18	0.45	0.68	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	23.12	7.14	0.75	0.21	0.32	0.32
Preadipocyte - omental, donor2	11329-117E6	20.51	3.49	0.44	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	21.06	5.01	1.00	0.29	0.57	0.43
Preadipocyte - perirenal, donor1	11469-119C2	7.87	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	3.69	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	43.38	17.53	2.30	1.59	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	26.73	8.34	1.36	0.34	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	43.22	21.98	2.61	1.12	0.37	0.47
Preadipocyte - visceral, donor2	11357-117H7	41.88	11.50	0.92	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	24.76	12.43	1.78	0.42	0.21	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	78.59	11.31	2.87	0.75	0.45	0.75
Prostate Epithelial Cells, donor2	11331-117E8	18.69	2.57	0.68	0.00	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	30.62	2.76	0.12	0.31	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	46.70	5.81	1.94	0.46	0.46	0.57
Prostate Stromal Cells, donor2	11332-117E9	45.18	7.71	0.90	0.00	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	20.54	4.90	0.63	0.31	0.21	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	2.92	0.36	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.08	11.64	0.90	1.11	0.35	0.35
Renal Epithelial Cells, donor1	11517-119H5	8.62	4.06	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	0.71	2.85	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	26.15	15.88	0.95	0.53	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	3.40	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.14	6.47	0.27	0.40	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	46.18	20.42	1.55	0.22	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	2.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.04	2.42	0.22	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	6.90	3.76	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.50	1.66	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	10.74	5.37	0.27	0.54	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	4.22	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.34	5.40	0.19	0.96	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	33.97	29.04	2.07	1.30	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.97	4.26	0.57	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	4.12	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.59	5.02	0.25	1.00	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	44.63	33.94	3.47	0.67	0.27	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	22.34	23.23	0.00	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	47.33	56.69	2.20	3.85	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	42.92	60.91	2.90	6.96	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	45.51	29.00	3.25	2.73	0.65	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	46.18	31.68	3.57	0.89	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	59.00	37.92	4.13	3.12	0.78	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	63.51	37.21	2.36	2.48	0.50	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	48.60	32.40	3.61	1.86	0.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	57.09	46.69	4.85	1.62	0.46	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	35.73	27.66	3.15	2.60	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	49.77	36.91	3.18	1.97	0.61	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	48.20	45.16	4.66	1.25	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	38.30	27.69	2.44	1.43	0.72	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	49.69	35.41	3.54	2.04	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	41.16	36.51	3.98	2.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	35.56	26.96	3.44	1.72	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	55.34	34.47	3.73	1.12	0.28	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	76.29	43.22	2.82	3.76	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	43.40	30.12	2.92	1.86	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.46	35.82	4.09	0.97	0.68	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	51.18	41.06	3.63	1.15	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.64	26.38	1.82	1.82	0.64	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.89	35.32	2.52	1.68	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	52.81	39.99	3.76	1.54	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	39.02	27.71	3.65	1.82	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.13	33.72	3.92	0.49	0.37	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	46.34	42.98	4.16	1.48	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.97	25.47	1.65	1.65	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	48.81	36.31	2.18	2.58	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	50.51	50.28	2.81	3.51	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	33.38	27.58	3.94	1.24	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	55.74	29.20	2.43	2.21	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	39.90	34.67	3.55	1.04	0.42	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.13	23.82	4.04	1.88	0.81	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	58.41	27.76	2.38	1.53	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.38	40.68	3.08	1.74	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	44.19	27.68	3.78	2.58	0.69	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.85	31.41	2.33	1.10	0.82	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	65.50	39.07	3.78	1.97	0.49	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	35.11	27.95	2.39	2.05	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	54.15	36.99	3.55	0.74	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	58.64	43.71	6.93	1.60	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	46.18	22.81	2.21	1.94	0.41	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.95	39.05	2.62	1.19	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	51.19	57.44	4.64	3.02	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	36.45	25.24	2.35	2.07	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.37	36.68	2.79	2.45	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	58.33	24.48	2.12	3.02	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	32.92	32.07	2.08	1.84	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	123.14	59.68	6.70	4.95	1.60	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	61.45	37.72	2.43	2.43	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	32.55	28.33	2.11	1.21	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	64.46	31.67	2.26	1.81	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	69.19	63.20	3.00	3.89	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.75	24.09	2.36	2.24	0.83	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	54.00	34.36	1.71	1.49	0.85	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	58.90	63.70	3.61	0.60	0.00	1.80
Schwann Cells, donor1	11498-119F4	11.28	3.01	0.38	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	30.62	6.80	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.77	10.95	0.22	0.00	0.44	0.00
Sebocyte, donor1	11220-116B5	13.69	1.64	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	11.03	1.38	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	9.89	3.50	0.21	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	38.10	3.31	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	39.54	2.82	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	31.94	6.07	0.70	0.79	0.18	0.09
Skeletal Muscle Cells, donor2	11358-117H8	12.29	3.61	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	14.21	12.54	0.00	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	29.53	14.30	1.89	1.41	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	31.81	16.95	1.49	1.19	0.45	0.45
Skeletal Muscle Cells, donor6	11459-119B1	40.78	23.39	3.23	0.31	0.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.89	13.23	0.50	1.26	0.63	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	38.53	10.70	0.86	0.43	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	49.21	23.02	3.08	1.19	0.60	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	26.37	8.34	1.01	0.34	0.08	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	4.34	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.91	4.68	0.83	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	8.06	10.74	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.03	2.31	0.29	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	41.71	9.00	2.45	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.29	1.95	0.26	0.52	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	37.81	2.92	0.42	0.28	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	28.83	2.95	0.14	0.56	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	127.50	7.40	1.48	1.06	0.21	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	32.38	2.32	0.30	0.22	0.30	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.58	3.70	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.47	4.89	1.33	0.67	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	9.99	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.82	8.40	1.33	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.88	2.36	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.00	7.73	0.77	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	6.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	12.24	3.99	0.67	0.00	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.94	4.21	0.66	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.25	2.94	0.64	0.26	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.40	10.42	1.30	0.65	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.99	9.75	0.59	0.59	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.22	10.68	0.85	0.28	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	0.98	0.16	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.18	6.70	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.36	5.56	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	97.93	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	4.29	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.42	11.21	1.18	0.88	0.15	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.84	11.84	1.08	0.22	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.53	12.18	1.99	0.52	0.31	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.28	1.24	0.46	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.35	3.89	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.51	4.10	0.00	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	36.91	8.01	0.63	0.79	0.16	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	26.87	9.66	1.31	0.30	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.96	2.50	0.91	0.23	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.06	1.21	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	73.65	15.10	2.38	2.12	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.70	5.73	0.53	0.53	0.80	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	29.55	3.76	0.75	0.50	0.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.68	2.54	0.51	0.00	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.03	5.28	1.36	0.15	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	4.50	0.75	2.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	38.77	10.34	2.58	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	16.74	6.05	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	23.73	2.52	0.00	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.98	2.19	0.63	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	1.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	48.65	11.91	1.50	1.08	0.83	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	9.81	0.47	0.93	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.48	2.01	0.72	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.57	5.10	0.76	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.90	3.20	0.38	0.38	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	47.79	15.93	2.24	0.84	0.98	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.99	5.61	0.42	0.17	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	1.90	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.58	1.47	0.49	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.04	2.65	1.55	0.44	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.82	7.61	1.46	1.76	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.91	10.11	0.39	0.39	0.39	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.42	5.29	0.79	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.51	10.79	0.37	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	18.69	9.34	1.44	0.00	1.08	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.49	4.26	1.70	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.00	10.63	0.79	1.18	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	10.16	0.00	0.51	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	11.58	15.57	0.00	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	12.54	0.84	0.00	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	11.46	14.21	0.92	0.46	0.00	0.92
Synoviocyte, donor1	11291-117A4	17.67	4.71	0.84	0.34	0.34	0.50
Synoviocyte, donor2	11368-117I9	15.59	6.54	0.84	0.17	0.34	0.00
Synoviocyte, donor3	11440-118H9	13.63	5.14	0.22	0.89	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	8.93	5.36	1.07	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	6.25	0.46	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	13.84	3.87	0.43	0.36	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	1.93	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	1.72	0.00	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.95	30.14	2.71	1.60	0.49	0.12
Urethra, donor2	10319-105A4	8.99	19.78	5.40	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	3.98	1.59	0.27	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	4.41	1.60	0.40	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	5.96	0.46	0.46	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	23.63	7.80	0.67	0.22	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	19.58	14.24	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	38.60	30.02	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	21.90	0.00	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.30	27.89	0.00	1.03	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	25.57	23.82	0.00	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	19.78	18.74	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	11.93	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	43.82	16.43	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	81.30	16.90	4.56	0.00	0.62	0.62
Wilms' tumor cell line:HFWT	10597-108E3	53.68	6.16	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.71	18.43	1.68	1.12	0.84	0.00
achilles tendon, donor2	10292-104G4	16.53	6.20	10.33	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	51.76	51.50	4.59	1.78	1.78	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	82.19	34.13	4.41	1.39	1.86	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	80.72	50.81	3.21	2.26	2.26	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	58.23	54.69	7.89	0.82	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	75.89	13.49	1.69	1.69	1.69	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	36.80	28.97	1.90	1.27	0.85	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	31.30	38.11	2.99	2.99	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	36.57	35.25	3.53	2.20	1.32	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	37.16	34.71	2.04	1.23	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	48.54	39.22	1.55	1.55	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	46.92	20.98	2.02	0.74	0.55	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	19.50	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	45.08	48.34	3.95	1.39	1.39	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	54.11	53.85	3.11	2.85	0.52	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	51.43	36.82	4.68	2.63	1.46	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	46.48	15.80	2.79	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	36.60	11.52	1.65	0.82	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	26.09	6.14	2.76	0.31	0.92	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	73.82	23.47	5.12	1.71	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	64.90	14.86	4.55	1.82	0.30	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	76.06	21.42	4.81	2.17	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	64.37	38.98	3.79	2.45	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	69.71	13.01	1.67	0.67	0.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	18.58	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	76.84	25.99	3.01	0.75	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	33.15	28.35	1.74	1.31	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	3.75	1.87	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	37.21	15.78	2.35	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	19.23	26.06	0.62	1.09	0.16	0.16
adipose, donor1	10184-103D4	184.13	91.48	11.14	1.76	0.59	1.17
adipose, donor2	10185-103D5	155.72	6.49	4.46	0.00	2.03	0.81
adipose, donor3	10186-103D6	158.47	19.88	5.72	1.09	0.82	0.54
adipose, donor4	10187-103D7	164.68	116.14	10.40	5.20	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.98	69.44	5.21	1.26	0.95	0.00
adrenal gland, adult, pool1	10081-102A9	29.10	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.02	53.63	3.87	1.33	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	19.65	72.17	5.00	1.43	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	20.63	6.26	0.00	0.46	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	26.71	13.19	1.69	0.34	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	21.21	5.89	0.00	0.88	0.00	0.00
amygdala - adult, donor10196	10167-103B5	23.72	15.42	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	61.64	54.34	3.65	0.81	0.41	0.61
amygdala, newborn, donor10223	10360-105E9	45.83	17.11	3.87	0.32	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	22.41	4.97	0.64	0.64	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	54.27	30.45	3.53	0.00	0.44	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	93.20	26.72	4.34	1.00	0.67	0.67
aorta, adult, pool1	10052-101G7	45.31	9.61	0.20	0.59	0.39	0.39
appendix, adult	10189-103D9	41.14	27.56	0.78	0.78	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.43	28.55	0.69	0.69	1.03	0.00
artery, adult	10190-103E1	24.46	17.66	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	42.59	15.07	1.01	0.87	0.43	1.88
b cell line:RPMI1788	10427-106D4	28.55	25.58	2.38	0.45	1.04	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.37	4.72	0.55	0.00	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	30.96	15.18	1.39	0.79	0.40	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	25.94	9.37	1.00	0.33	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	60.96	12.30	1.12	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	34.55	16.30	0.43	0.65	0.76	0.54
blood, adult, pool1	10053-101G8	48.72	17.72	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	2.57	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	28.34	17.55	2.70	2.02	1.35	0.00
brain, adult, donor1	10084-102B3	23.58	16.40	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	27.73	19.49	1.00	0.78	0.45	0.56
brain, fetal, pool1	10085-102B4	29.39	10.69	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	73.34	12.88	0.66	0.99	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	35.70	15.48	1.25	0.12	0.00	0.37
breast, adult, donor1	10080-102A8	29.04	32.20	1.89	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.68	8.00	0.89	0.13	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.67	17.63	1.55	0.00	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	17.27	62.39	2.53	2.76	1.15	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	50.35	16.46	1.45	0.48	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	41.84	58.30	2.35	4.70	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	36.53	11.81	1.75	0.88	0.33	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	43.73	58.94	1.58	1.58	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	135.22	50.84	3.46	1.33	1.60	1.33
caudate nucleus - adult, donor10196	10177-103C6	16.12	25.33	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	62.08	35.81	2.01	0.50	0.84	0.00
caudate nucleus, adult, donor10258	10379-105H1	22.92	12.99	0.76	0.00	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	77.64	17.21	2.56	0.37	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	14.57	69.92	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	71.53	106.33	2.99	3.20	2.56	0.85
cerebellum, adult, pool1	10083-102B2	36.91	24.49	0.69	1.38	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	172.70	80.54	0.83	1.66	0.83	1.66
cerebral meninges, adult	10188-103D8	28.74	19.16	1.51	0.25	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	10.96	15.35	0.73	0.73	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	29.62	35.95	0.72	1.44	1.44	0.58
cervical cancer cell line:ME-180	10553-107I4	41.43	18.56	2.65	0.50	0.50	0.00
cervix, adult, pool1	10013-101C4	44.83	28.24	0.84	1.78	0.42	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.34	21.18	2.37	0.56	0.28	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	16.98	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	76.80	7.46	1.37	1.99	0.99	0.50
choriocarcinoma cell line:SCH	10785-110H2	73.80	16.02	6.41	1.11	0.49	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	65.22	7.59	2.85	1.42	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	25.93	0.85	0.28	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	30.23	12.33	1.89	0.70	0.70	0.20
chorionic membrane cells, donor3	12240-129G8	29.67	3.30	0.55	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	41.40	14.14	1.01	2.02	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	52.83	14.60	1.92	0.38	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	56.39	21.54	1.90	0.21	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	83.72	13.61	1.54	1.28	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	97.96	14.51	2.66	0.73	1.45	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	98.55	14.46	4.07	1.63	0.61	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	64.49	22.67	4.12	1.47	1.77	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	58.12	20.33	5.73	2.61	1.56	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.86	19.43	1.83	0.91	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	21.69	16.14	1.04	0.87	1.39	0.52
colon carcinoma cell line:CACO-2	10513-107D9	69.56	10.98	4.21	1.10	0.73	0.37
colon carcinoma cell line:COLO-320	10420-106C6	47.89	63.09	1.90	2.66	0.76	0.76
colon, adult, donor1	10082-102B1	42.84	5.95	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	23.97	18.92	0.35	0.71	0.82	0.24
colon, fetal, donor1	10070-101I7	50.06	12.36	1.24	1.85	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	160.42	45.84	0.00	0.00	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	46.32	5.95	0.85	0.85	2.12	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	54.34	12.38	4.08	0.75	0.60	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	46.53	7.47	4.37	0.71	0.56	0.99
corpus callosum, adult, pool1	10042-101F6	36.82	28.75	1.99	0.88	1.11	0.44
cruciate ligament, donor2	10295-104G7	24.31	21.88	0.81	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	23.27	39.33	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	20.40	18.24	0.96	1.20	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	50.74	30.31	1.38	0.46	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	69.75	14.62	1.80	1.80	1.54	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	35.15	22.39	3.85	0.72	0.24	1.93
ductus deferens, adult	10196-103E7	53.32	13.46	0.50	1.00	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	34.57	30.24	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	42.67	27.95	0.00	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	30.47	8.51	0.41	0.58	0.50	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	98.38	2.89	3.55	2.44	0.22	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	62.62	16.62	3.87	3.01	1.00	3.01
embryonic pancreas cell line:1B2C6	10604-108F1	17.88	24.66	0.62	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	19.37	19.68	0.30	0.30	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.63	22.54	1.23	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	19.70	6.57	1.31	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	30.17	6.37	1.68	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	33.17	21.02	2.17	1.45	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	19.94	12.38	1.93	0.48	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	37.68	11.45	1.45	0.78	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	44.98	46.08	3.85	1.76	1.32	1.21
epididymis, adult	10197-103E8	32.23	14.02	0.63	1.47	0.84	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.14	47.72	1.24	0.89	3.02	2.13
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.45	7.47	0.79	0.79	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	78.63	47.96	7.60	1.70	1.44	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	74.21	37.89	7.09	2.66	0.79	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	82.34	54.89	7.84	0.56	1.68	0.22
esophagus, adult, pool1	10015-101C6	33.13	14.44	0.85	1.17	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	128.62	43.21	13.02	3.13	1.38	2.00
eye - muscle inferior rectus, donor1	10272-104E2	31.39	9.66	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	23.15	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	14.88	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	17.20	1.15	0.00	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	48.09	11.66	2.91	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	57.46	17.29	0.76	0.25	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	32.06	10.26	0.90	0.64	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	50.33	34.43	3.09	1.42	0.95	0.47
frontal lobe, adult, pool1	10040-101F4	36.59	17.92	1.60	0.84	0.66	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	145.32	24.92	3.90	1.50	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.29	12.34	0.73	0.46	0.18	0.00
gall bladder, adult	10198-103E9	33.32	14.49	0.97	0.24	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	24.70	26.84	0.54	0.54	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	25.40	25.40	1.12	1.12	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	54.28	8.87	1.27	0.63	0.21	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	34.04	21.08	1.35	0.39	0.97	0.77
gastric cancer cell line:AZ521	10549-107H9	28.20	70.50	5.90	1.80	1.48	0.82
gastric cancer cell line:GSS	10560-108A2	20.13	32.95	0.00	3.66	3.66	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	43.18	26.04	3.43	2.97	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	10.21	12.39	0.57	0.80	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	25.05	42.41	1.12	1.54	0.70	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	64.60	9.48	1.50	0.50	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.39	19.95	0.95	0.95	0.11	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.44	21.49	2.25	0.98	0.28	0.56
glioblastoma cell line:T98G	10485-107A8	34.66	20.64	0.88	0.88	0.66	0.22
glioma cell line:GI-1	10413-106B8	34.27	19.62	2.05	1.17	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	25.51	20.41	4.37	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	79.09	76.89	8.30	2.93	0.49	1.22
globus pallidus, adult, donor10258	10367-105F7	36.97	26.01	2.74	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	53.29	18.12	3.73	0.00	0.53	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	166.41	41.60	4.89	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	23.04	13.76	0.32	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	94.58	40.40	8.26	1.84	1.84	0.46
hIPS +CCl2, biol_rep2	14384-156C1	85.97	28.81	7.32	0.91	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	97.90	28.34	4.51	0.64	1.29	0.64
hIPS, biol_rep1	14380-156B6	119.29	12.94	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	73.39	30.18	2.06	1.37	0.69	0.00
hIPS, biol_rep3	14382-156B8	37.52	19.86	4.41	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	65.80	14.08	5.46	0.57	0.57	0.00
heart - mitral valve, adult	10205-103F7	27.21	16.14	0.30	0.30	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	25.36	14.38	0.52	0.78	0.78	0.52
heart - tricuspid valve, adult	10207-103F9	56.62	34.14	0.00	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	26.12	12.04	0.82	0.82	1.22	0.00
heart, adult, diseased, donor1	10051-101G6	14.48	11.07	0.43	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	19.78	22.77	1.15	0.46	1.84	0.69
heart, fetal, pool1	10046-101G1	55.86	23.92	0.82	0.62	0.72	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.92	4.63	1.23	0.31	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	47.57	27.35	2.38	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	66.96	65.63	7.73	2.21	0.77	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	74.04	64.33	8.25	2.79	0.97	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	74.68	69.42	7.58	3.33	1.62	1.41
hepatoma cell line:Li-7	10484-107A7	14.68	15.90	1.56	0.44	0.78	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	58.99	35.48	3.72	1.51	0.60	0.30
hippocampus - adult, donor10196	10169-103B7	29.34	27.44	1.89	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	60.41	56.94	6.12	0.82	0.61	0.41
hippocampus, adult, donor10258	10374-105G5	22.91	9.96	1.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	48.29	14.10	4.58	0.35	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	126.34	81.79	17.09	9.16	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	80.70	39.47	9.23	3.93	1.18	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	92.16	54.59	10.41	4.32	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	73.30	41.16	6.77	0.00	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	93.47	39.25	4.39	1.81	2.32	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	86.93	35.68	4.18	0.00	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	202.32	2.92	4.67	0.88	0.58	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	211.34	4.09	3.23	0.43	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	170.17	7.09	3.75	0.42	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	117.21	0.00	0.95	0.47	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	132.27	1.29	1.13	0.96	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	84.16	0.00	2.02	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	82.15	41.16	8.92	4.07	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	82.54	34.88	10.81	3.44	0.98	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	75.06	66.33	13.96	8.73	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	99.85	37.04	3.82	0.76	0.95	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	83.29	30.09	1.31	0.44	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	101.45	70.47	4.00	1.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	161.26	4.90	2.26	0.19	0.94	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	153.69	5.00	4.09	0.45	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	149.73	4.70	1.88	0.94	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	109.25	1.80	1.47	0.00	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	103.06	1.16	0.58	0.00	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	129.43	2.39	0.90	0.00	1.20	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	96.99	42.68	8.50	3.14	0.92	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	90.15	33.38	9.41	3.71	0.86	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	133.52	69.82	20.82	3.67	1.22	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	90.48	27.81	3.87	1.41	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	82.99	20.59	3.48	0.95	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	93.51	31.78	3.63	0.61	0.61	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	100.84	5.69	2.07	0.00	1.55	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	98.96	5.98	1.99	0.00	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	98.51	5.90	3.59	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	91.27	2.81	0.77	1.02	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	127.97	3.03	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	95.78	4.03	2.69	0.67	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	113.99	40.57	12.80	4.11	2.17	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	107.40	47.69	14.71	3.12	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	118.05	46.83	15.12	2.93	2.44	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	113.69	29.64	3.36	1.53	2.44	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	351.35	97.60	16.27	13.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	117.48	38.72	5.30	2.65	2.32	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	161.45	3.28	2.74	0.55	1.09	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	150.91	3.62	3.26	0.72	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	140.57	4.27	2.49	0.36	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	152.75	1.19	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	171.45	2.03	2.17	0.14	0.14	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	99.14	1.35	2.16	0.00	0.54	0.00
immature langerhans cells, donor1	11904-125F5	19.13	7.75	0.97	0.24	0.73	1.70
immature langerhans cells, donor2	11905-125F6	19.01	10.30	0.00	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	35.96	21.86	1.80	1.14	0.57	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	47.47	7.15	0.98	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	37.75	10.41	0.50	0.70	0.30	0.20
kidney, fetal, pool1	10045-101F9	41.10	9.20	0.92	0.85	0.28	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	60.50	10.23	1.99	0.43	0.43	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.10	6.22	0.83	0.14	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.18	6.24	0.73	0.73	0.73	0.37
left atrium, adult, donor1	10079-102A7	7.08	16.35	0.54	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	32.87	12.64	0.00	0.00	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	42.68	48.98	2.46	1.92	1.64	0.55
leiomyoma cell line:10964C	10569-108B2	20.48	0.36	0.36	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	13.59	2.17	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	19.18	2.91	0.24	0.49	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	9.41	0.00	0.00	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	52.65	19.48	2.60	0.35	0.71	0.71
liposarcoma cell line:KMLS-1	10782-110G8	43.11	24.37	3.44	0.62	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	47.52	10.48	1.83	0.24	0.37	0.12
liver, adult, pool1	10018-101C9	13.94	15.56	1.30	0.81	0.16	0.00
liver, fetal, pool1	10086-102B5	20.70	10.35	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	34.41	24.79	2.77	1.46	0.15	0.87
locus coeruleus, adult, donor10252	10165-103B3	56.10	44.85	5.17	2.21	0.74	0.55
locus coeruleus, adult, donor10258	10375-105G6	33.29	11.29	1.41	1.13	0.00	0.85
locus coeruleus, newborn, donor10223	10362-105F2	43.74	17.25	2.10	1.68	1.26	1.68
lung adenocarcinoma cell line:A549	10499-107C4	14.67	15.09	0.97	1.11	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	11.72	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	29.66	8.30	1.05	0.00	0.00	0.26
lung, adult, pool1	10019-101D1	29.18	15.83	1.06	0.47	0.47	0.71
lung, fetal, donor1	10068-101I5	70.78	36.25	3.14	1.43	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	40.32	19.70	1.37	0.92	1.83	0.00
lymph node, adult, donor1	10077-102A5	34.08	17.04	0.95	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	33.75	28.27	2.85	1.10	1.10	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	37.73	103.99	4.38	4.53	6.64	4.68
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	114.68	8.49	0.85	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	14.21	14.65	0.00	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	12.87	15.36	0.00	0.62	0.00	0.21
mature adipocyte, donor3	12233-129G1	7.35	9.48	0.00	0.95	0.24	0.00
mature adipocyte, donor4	12234-129G2	18.95	18.16	0.53	1.84	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	41.93	17.15	1.19	0.48	0.48	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	16.92	21.43	2.26	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	54.80	50.21	2.57	1.29	0.18	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	25.73	17.16	0.00	1.27	0.32	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	62.27	24.31	4.69	2.56	0.43	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	28.35	33.58	1.69	1.18	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	60.91	52.63	3.82	2.12	0.42	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	9.63	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	200.95	14.35	43.06	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	49.89	15.43	1.44	1.08	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	22.07	18.82	1.95	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	59.29	48.45	6.04	2.17	0.93	0.93
medulla oblongata, adult, pool1	10038-101F2	34.94	15.84	0.90	0.65	0.24	0.98
medulla oblongata, newborn, donor10223	10361-105F1	61.10	24.65	3.12	1.39	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	69.52	100.96	7.53	1.55	1.77	0.00
medulloblastoma cell line:ONS-76	10759-110E3	60.77	11.37	3.55	0.86	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	34.21	7.19	2.44	0.43	0.14	0.72
melanoma cell line:G-361	10465-106H6	61.08	23.35	1.63	0.00	0.54	2.71
meningioma cell line:HKBMM	10691-109F7	18.45	9.23	0.18	0.54	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	111.91	20.27	2.64	3.52	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	81.66	25.66	3.11	0.78	1.30	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.95	10.43	1.99	1.38	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.27	8.18	0.91	1.09	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.63	5.38	1.66	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.71	11.80	0.84	0.70	0.28	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3.85	13.48	0.77	0.39	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	12.49	7.63	0.00	0.00	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.67	6.69	0.51	0.17	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	13.34	11.62	0.81	0.58	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	15.25	11.01	0.27	0.66	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.23	11.48	1.49	0.54	0.81	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.80	14.94	1.71	1.14	0.85	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	8.89	1.32	0.00	0.66	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.65	11.48	1.52	0.42	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.36	7.68	0.70	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.07	8.37	0.41	0.20	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.06	7.91	0.72	0.36	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.00	8.90	0.41	0.21	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.72	4.56	0.68	0.23	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.79	10.07	0.42	1.26	1.26	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.89	11.81	1.34	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.98	12.34	0.96	0.61	0.35	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6.63	19.88	0.74	0.74	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	11.16	7.73	0.57	1.14	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	50.94	16.00	0.42	0.84	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.90	2.28	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	22.00	6.65	0.77	0.51	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.32	5.50	1.05	0.52	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.87	3.08	1.23	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	23.30	5.18	0.24	0.24	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	23.69	5.08	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.79	5.89	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	21.32	7.41	0.93	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.98	7.21	1.15	0.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	20.97	6.47	0.22	0.67	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	20.67	5.05	0.96	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	3.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.12	4.03	0.34	0.67	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.47	4.91	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	6.44	1.29	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.86	7.79	0.97	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	2.91	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	4.26	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	4.09	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.10	3.89	0.39	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	6.30	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	2.98	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	14.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	3.56	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	3.17	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.76	9.31	1.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.22	5.70	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	6.36	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	7.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.53	5.61	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	4.01	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	10.64	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	30.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	6.20	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	3.96	17.32	0.49	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	4.49	12.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.72	13.36	0.00	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.43	15.31	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	10.90	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	6.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.03	7.89	0.00	1.82	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1.65	11.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.56	9.52	0.79	0.20	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	15.25	1.30	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	11.20	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	6.96	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.59	20.32	1.42	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	39.62	24.56	2.78	0.46	0.46	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	76.92	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	34.83	39.35	4.42	1.34	1.23	1.64
mesothelioma cell line:Mero-25	10850-111F4	24.96	2.27	1.59	0.45	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	30.80	11.25	1.47	0.24	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	41.19	4.65	1.33	0.00	0.00	1.11
mesothelioma cell line:Mero-82	10853-111F7	65.18	3.94	1.84	0.53	0.79	0.53
mesothelioma cell line:Mero-83	10854-111F8	33.53	16.85	3.23	1.02	1.02	0.17
mesothelioma cell line:Mero-84	10855-111F9	15.42	15.67	1.01	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	31.26	4.97	0.83	0.21	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	44.56	48.37	6.13	0.66	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	42.71	7.78	2.53	0.72	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	47.15	8.88	0.68	0.68	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	57.51	8.40	2.29	0.25	0.51	0.00
mesothelioma cell line:No36	10857-111G2	21.20	18.59	2.61	1.30	0.65	1.30
mesothelioma cell line:ONE58	10858-111G3	28.45	11.65	2.98	0.81	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	41.65	4.03	0.58	1.73	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	47.01	2.93	1.10	0.73	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	39.84	1.97	0.18	1.08	1.08	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	56.15	4.24	0.65	0.00	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	38.78	12.29	0.64	0.21	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.49	4.15	0.23	0.23	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.16	15.03	2.28	0.38	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	28.27	46.57	2.22	2.22	2.03	0.18
myeloma cell line:PCM6	10474-106I6	12.26	10.67	0.20	0.59	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.32	12.68	2.03	1.52	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.97	28.83	1.96	1.37	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	21.39	2.67	0.33	0.45	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.08	3.16	0.29	0.22	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	51.89	24.29	4.42	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	93.63	8.97	1.15	0.92	1.15	0.46
neuroblastoma cell line:NB-1	10539-107G8	70.34	35.55	2.99	2.43	2.06	2.43
neuroblastoma cell line:NBsusSR	10607-108F4	59.26	9.49	0.21	0.42	0.63	0.42
neuroblastoma cell line:NH-12	10555-107I6	127.46	19.75	1.86	0.93	0.37	2.98
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	63.58	19.45	2.85	0.47	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	62.56	36.11	1.43	0.63	0.95	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	22.74	53.33	2.82	1.81	1.41	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	28.61	47.68	5.72	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	30.88	5.06	1.33	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	47.35	157.96	5.75	2.88	4.90	4.06
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	45.63	20.81	2.40	3.20	1.60	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	42.32	6.41	0.32	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.71	3.94	0.53	0.00	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	31.22	19.31	1.59	1.03	0.28	0.75
occipital cortex - adult, donor10196	10172-103C1	18.54	47.39	4.12	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	74.34	57.43	6.71	2.68	0.54	1.07
occipital cortex, newborn, donor10223	10355-105E4	53.86	18.93	6.55	0.73	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	29.39	22.57	1.84	1.05	0.79	0.79
occipital lobe, fetal, donor1	10073-102A1	102.98	25.32	3.43	1.72	0.43	0.86
occipital pole, adult, pool1	10036-101E9	16.64	9.70	1.10	0.87	0.00	0.24
olfactory region, adult	10195-103E6	26.37	21.40	1.34	1.34	0.96	0.19
optic nerve, donor1	10277-104E7	58.03	8.00	2.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	22.90	16.52	2.96	0.46	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	70.34	23.36	1.24	0.69	0.69	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	39.62	6.10	0.17	0.51	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	47.82	6.35	0.81	0.69	0.23	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	31.75	5.88	0.59	0.29	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	7.47	0.93	0.00	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	22.69	39.87	5.51	0.42	0.42	1.70
ovary, adult, pool1	10020-101D2	48.83	19.04	0.87	1.48	0.96	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	28.23	12.47	1.65	0.37	0.92	0.55
pancreas, adult, donor1	10049-101G4	54.56	19.75	3.76	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	53.95	4.75	0.84	1.68	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	50.94	3.92	1.02	0.17	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	37.26	17.39	1.82	0.83	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	27.37	19.68	1.65	0.73	0.09	0.27
parietal cortex, adult, donor10258	10373-105G4	28.63	24.22	2.94	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	21.63	31.98	0.94	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	57.86	44.18	5.99	1.14	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	32.16	18.24	2.29	0.62	0.09	0.70
parietal lobe, fetal, donor1	10072-101I9	120.26	42.67	1.94	4.85	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	50.47	17.20	2.24	0.37	1.12	1.50
parotid gland, adult	10199-103F1	8.02	9.87	0.00	1.85	0.00	0.62
penis, adult	10200-103F2	26.86	17.19	0.54	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	52.06	6.69	1.49	0.37	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.39	33.22	1.02	0.73	1.31	0.15
pineal gland - adult, donor10196	10179-103C8	60.63	12.26	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	151.61	18.36	0.59	3.55	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	78.38	8.15	0.63	1.88	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	21.25	19.22	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	63.06	26.58	0.52	4.17	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	23.83	14.47	1.70	2.55	0.00	0.00
placenta, adult, pool1	10021-101D3	41.93	11.50	1.18	0.54	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	32.31	25.56	2.52	1.46	1.32	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	33.31	8.25	0.93	0.62	0.47	0.00
pons, adult, pool1	10033-101E6	28.23	18.59	1.81	0.86	0.43	1.03
postcentral gyrus, adult, pool1	10032-101E5	21.27	12.20	1.22	0.78	0.17	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	87.84	12.55	0.00	2.09	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.59	76.76	3.79	0.73	0.73	0.15
prostate cancer cell line:PC-3	10439-106E7	42.47	45.74	1.63	1.09	1.45	1.27
prostate, adult, pool1	10022-101D4	44.44	19.68	1.18	0.73	0.36	0.45
putamen, adult, donor10196	10176-103C5	43.91	31.16	2.12	0.47	0.47	0.24
putamen, adult, donor10252	10152-102I8	33.33	23.53	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	56.83	16.39	3.28	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	16.67	15.95	0.24	1.21	0.24	0.24
putamen, newborn, donor10223	10365-105F5	59.97	19.49	0.75	1.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	32.29	5.82	1.16	1.16	0.29	0.29
rectum, fetal, donor1	10067-101I4	136.32	30.60	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	23.32	16.32	0.21	1.06	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.08	8.70	0.83	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	41.95	13.92	1.29	0.99	0.40	0.30
retinoblastoma cell line:Y79	10475-106I7	74.30	78.20	4.42	2.86	1.04	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	58.52	35.66	4.67	0.98	0.61	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	108.82	26.15	3.94	1.69	0.84	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	21.22	6.82	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	21.20	5.02	0.49	0.16	0.16	0.32
salivary acinar cells, donor2	11772-123I8	34.83	3.99	0.69	0.41	0.00	0.28
salivary acinar cells, donor3	11773-123I9	17.88	4.63	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	20.59	2.29	0.00	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.98	29.17	1.69	1.26	0.51	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.86	31.50	2.59	0.59	0.82	1.18
seminal vesicle, adult	10201-103F3	61.37	13.76	1.06	3.17	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	43.97	17.73	0.49	0.97	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.53	11.07	0.25	0.25	0.75	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	19.07	0.00	0.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	49.16	4.16	2.28	0.54	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	81.24	6.96	2.10	1.11	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	51.35	7.87	1.55	0.90	0.39	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	19.86	4.26	2.13	0.00	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	37.78	19.43	1.92	0.84	1.44	3.00
skeletal muscle, fetal, donor1	10066-101I3	23.12	12.06	3.02	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	77.64	42.29	3.16	2.52	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	59.03	23.68	4.67	0.33	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	105.91	36.25	0.95	3.15	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	32.00	74.79	9.44	1.93	0.39	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	83.07	11.70	3.13	1.48	1.15	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	85.57	34.42	4.66	1.93	0.64	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	95.67	14.38	1.96	1.31	2.40	1.09
small intestine, adult, pool1	10024-101D6	31.41	16.96	0.48	1.19	0.24	0.12
small intestine, fetal, donor1	10064-101I1	53.07	14.99	1.23	0.98	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	59.50	10.26	2.05	0.51	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	46.00	11.37	0.26	0.00	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	46.10	5.90	0.27	0.27	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	36.25	35.33	1.38	3.21	0.46	0.69
spinal cord, adult, donor10252	10159-103A6	62.29	44.16	7.89	1.58	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	22.83	9.69	0.69	0.69	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	54.28	39.64	3.05	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	70.26	28.47	4.59	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	43.16	4.93	0.60	0.15	0.00	0.15
spleen, adult, pool1	10025-101D7	19.93	28.30	1.21	0.77	0.77	0.33
spleen, fetal, pool1	10044-101F8	25.82	19.23	0.72	0.32	0.40	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	46.79	34.57	2.48	1.24	0.72	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	17.47	4.94	0.19	0.19	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	38.09	22.71	1.75	1.05	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.46	3.13	0.39	0.78	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	36.69	5.97	0.34	0.45	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	36.01	95.31	1.69	2.54	3.39	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.04	17.77	2.12	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	60.87	20.29	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	21.08	10.25	0.57	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	60.23	61.69	7.06	1.66	0.42	1.04
substantia nigra, adult, donor10258	10371-105G2	17.59	15.52	0.52	1.03	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	50.17	16.25	1.41	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.66	60.07	5.27	1.60	2.06	0.92
temporal lobe, adult, pool1	10031-101E4	17.63	12.04	0.59	0.42	0.59	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	76.92	17.81	1.42	1.42	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	64.17	20.22	1.32	0.44	0.88	0.00
tenocyte, donor1	11763-123H8	28.63	9.43	0.00	0.35	0.70	0.35
tenocyte, donor2	11765-123I1	14.88	9.54	0.76	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	22.98	4.08	0.74	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	126.11	38.58	7.48	1.87	1.70	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	60.89	42.54	4.01	1.70	0.31	0.31
teratocarcinoma cell line:PA-1	10807-111A6	93.14	30.22	3.87	1.39	0.77	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	90.01	14.60	5.46	0.76	1.02	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	144.46	13.24	0.76	1.51	1.89	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	42.43	7.85	0.98	2.94	0.55	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	154.71	2.93	4.56	0.33	0.65	0.33
testis, adult, pool1	10026-101D8	42.73	36.40	4.62	1.40	1.61	1.07
testis, adult, pool2	10096-102C6	50.52	38.34	7.22	2.26	0.90	0.90
thalamus - adult, donor10196	10168-103B6	28.70	27.60	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	58.92	63.76	5.63	2.66	0.31	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	6.16	1.54	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.80	10.38	0.82	0.16	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	69.61	11.51	4.03	0.58	0.00	0.58
throat, adult	10209-103G2	30.71	13.98	0.50	0.25	0.75	0.25
throat, fetal, donor1	10061-101H7	68.25	28.03	1.22	0.91	0.30	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	56.44	29.21	2.58	0.60	0.60	0.60
thymus, adult, pool1	10027-101D9	95.54	35.09	3.28	1.49	0.80	1.19
thymus, fetal, pool1	10043-101F7	97.15	32.52	2.39	1.35	1.45	2.70
thyroid carcinoma cell line:KHM-5M	10776-110G2	39.22	13.43	1.73	1.06	0.00	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	44.42	10.48	0.70	0.84	0.14	0.00
thyroid, adult, pool1	10028-101E1	54.59	11.01	0.56	1.31	0.19	0.37
thyroid, fetal, donor1	10060-101H6	70.40	15.29	0.53	0.00	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	23.03	10.93	0.23	0.93	0.93	0.93
tongue, fetal, donor1	10059-101H5	29.16	30.35	2.76	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	37.17	17.53	1.00	0.50	0.50	0.10
trachea, adult, pool1	10029-101E2	29.94	13.25	0.57	1.23	0.98	0.08
trachea, fetal, donor1	10058-101H4	78.09	13.85	1.15	2.31	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	39.32	6.73	1.06	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	54.10	18.74	2.74	1.72	0.51	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	60.79	21.94	1.88	1.41	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	19.03	13.32	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.82	7.87	0.93	0.51	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	41.73	10.43	0.00	2.09	2.09	2.09
uterus, adult, pool1	10100-102D1	45.22	16.72	0.85	1.37	0.00	0.34
uterus, fetal, donor1	10055-101H1	96.24	24.57	1.54	2.05	1.02	0.00
vagina, adult	10204-103F6	68.50	56.87	3.88	0.00	0.65	0.00
vein, adult	10191-103E2	24.11	18.19	0.22	0.22	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.43	12.28	0.80	0.27	0.53	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000676783.1:197 ENST00000679035.1:215 ENST00000677150.1:-218 ENST00000678182.1:-248 AK312426:250 ENST00000677928.1:-252 ENST00000428210.5:-252 AL833550:-252 ENST00000677422.1:255 BC032847:-255 ENST00000406957.5:-269 ENST00000481214.1:277 CR749840:-279 BX647758:-287 ENST00000678790.1:-319 ENST00000677803.1:-377 ENST00000677239.1:-377 ENST00000401558.7:-377 NM_003400.4:-377 Y08614:378" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.